# The Study of GW493838, an Adenosine A1 Agonist, in Peripheral Neuropathic Pain

> **NCT00376454** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 113 (—)

## Conditions studied

- Neuropathic Pain

## Interventions

- **DRUG:** GW493838

## Key facts

- **NCT ID:** NCT00376454
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-11
- **Primary completion:** 2003-06
- **Final completion:** 2003-06
- **Target enrollment:** 113 (—)
- **Last updated:** 2013-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00376454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00376454, "The Study of GW493838, an Adenosine A1 Agonist, in Peripheral Neuropathic Pain". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00376454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*